Evelyn Partners Investment Management Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.88M Sell
18,071
-11,198
-38% -$6.08M 1.05% 26
2025
Q4
$17M Sell
29,269
-384
-1% -$217K 2.12% 15
2025
Q3
$14.4M Buy
29,653
+1,550
+6% +$721K 1.93% 18
2025
Q2
$11.4M Buy
28,103
+2,452
+10% +$1.03M 1.71% 19
2025
Q1
$12.8M Buy
25,651
+3,243
+14% +$1.76M 2.09% 15
2024
Q4
$11.7M Buy
+22,408
New +$12.3M 2.03% 15

Other funds holding TMO

Evelyn Partners Investment Management Services's TMO Position: Q1 2026 in Review

Evelyn Partners Investment Management Services reduced its Thermo Fisher Scientific (TMO) stake by 38% in Q1 2026, selling an estimated $6.08M and leaving 18,071 shares worth $8.88M. The position accounts for 1.05% of the portfolio, ranked #26.

Evelyn Partners Investment Management Services first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $17M in Q4 2025. 2,591 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Evelyn Partners Investment Management Services held 18,071 shares of Thermo Fisher Scientific worth $8.88M as of Q1 2026.
  • Evelyn Partners Investment Management Services sold 11,198 Thermo Fisher Scientific shares in Q1 2026, an estimated $6.08M.
  • Thermo Fisher Scientific made up 1.05% of Evelyn Partners Investment Management Services's portfolio in Q1 2026, its #26 holding.
  • Evelyn Partners Investment Management Services first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management Services's Thermo Fisher Scientific position peaked at $17M in Q4 2025.
  • 2,591 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Evelyn Partners Investment Management Services's 13F filing for Q1 2026, filed 15 May 2026.